Authors | S J Kim, K Kim, B S Kim, C Suh, J Huh, Y H Ko, W S Kim |
Journal | Annals of oncology : official journal of the European Society for Medical Oncology
(Ann Oncol)
Vol. 20
Issue 2
Pg. 390-2
(Feb 2009)
ISSN: 1569-8041 [Electronic] England |
PMID | 19211502
(Publication Type: Clinical Trial, Phase II, Letter, Multicenter Study)
|
Chemical References |
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm
- Antineoplastic Agents
- Cytarabine
- Alemtuzumab
- Dexamethasone
- Cisplatin
|
Topics |
- Adult
- Alemtuzumab
- Anemia
(chemically induced)
- Antibodies, Monoclonal
(therapeutic use)
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm
(therapeutic use)
- Antineoplastic Agents
(therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Cisplatin
(therapeutic use)
- Cytarabine
(therapeutic use)
- Dexamethasone
(therapeutic use)
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Humans
- Leukopenia
(chemically induced)
- Longitudinal Studies
- Lymphoma, T-Cell
(drug therapy)
- Lymphoma, T-Cell, Peripheral
(drug therapy)
- Male
- Middle Aged
- Prospective Studies
- Recurrence
- Salvage Therapy
- Survival Analysis
- T-Lymphocytes
(drug effects)
- Thrombocytopenia
(chemically induced)
- Treatment Outcome
- Young Adult
|